Epidemiology and Clinical Characteristics in Individuals with Confirmed SARS-CoV-2 Infection During the Early COVID-19 Pandemic in Saudi Arabia
Fatimah S Alhamlan, Reem S Almaghrabi, Edward B Devol, Anwar B Alotaibi, Saleh M Alageel, Dalia A Obeid, Basem M Alraddadi, Sahar I Althawadi, Maysoon S Mutabagani, Ahmed A Al-Qahtani
doi:10.1101/2021.07.13.21260428
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the catastrophic coronavirus disease 2019 global pandemic. This study aimed to provide epidemiologic and clinical characteristics of patients with confirmed COVID-19 in Saudi Arabia and to determine whether characteristic profiles differ between patients who are symptomatic vs. asymptomatic for the disease. The first 492 consecutive patients diagnosed with SARS-CoV-2 infection at King Faisal Specialist Hospital and Research Centre in Saudi Arabia between March and September 2020 were included in this study. An electronic case report form developed using REDCap was used to collect data for each patient, including demographic characteristics, virus exposure (travel history, and human and animal contact), vaccination history, comorbidities, signs and symptoms, laboratory and radiographic reports, cardiac workup, medications, treatment regimens, and patient outcome. This patient cohort was 54% male, with 20.4% aged more than 60 years, 19.9% aged 31 to 40 years, and 17% aged 41 to 50 years. Most patients (79.2%) were symptomatic. Variables that significantly differed between symptomatic and asymptomatic patients were age, blood oxygen saturation percentage, hemoglobin level, lymphocyte count, neutrophil to lymphocyte (NTL) ratio, alanine aminotransferase (ALT) level, and aspartate aminotransferase (AST) level. Asymptomatic patients were mostly younger, with lower body mass index and ALT and AST levels but higher lymphocyte counts, NTL ratio, and CD4, CD8, natural killer cell, IgG, and IgM levels. The median incubation period reported for this cohort was 16 day, with upper and lower 95% quartiles of 27 and 10 days, respectively. Factors associated with increased risk of mortality were age (older than 42 years) and comorbidities, including specifically diabetes mellitus and hypertension. Patients who were not given an antiviral regimen were associated with better prognosis than patients who received an antiviral regimen (HR, 0.07; 95% CI, 0.011-0.25). Similar to countries worldwide, Saudi Arabia has explored treatment options to save the lives of patients during the COVID-19 pandemic. Our analyses will inform clinicians as well as policy makers to adopt the best strategies for SARS-CoV-2 infection management and treatment options.
INTRODUCTION
References
Abbott, Hellewell, Munday, Funk, The transmissibility of novel Coronavirus in the early stages of the 2019-20 outbreak in Wuhan: Exploring initial point-source exposure sizes and durations using scenario analysis, Wellcome Open Res
Alene, Yismaw, Assemie, Ketema, Gietaneh et al., Serial interval and incubation period of COVID-19: a systematic review and metaanalysis, BMC Infect Dis
Axfors, Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials, Nat Commun
Bwire, Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women?, SN Compr Clin Med
Cao, A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19, N Engl J Med
Chen, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet
Consortium, Repurposed Antiviral Drugs for Covid-19 -Interim WHO Solidarity Trial Results, N Engl J Med
Cori, Ferguson, Fraser, Cauchemez, A new framework and software to estimate time-varying reproduction numbers during epidemics, Am J Epidemiol
Di Castelnuovo, Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study, Front Med (Lausanne)
Gao, Tian, Yang, Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends
Garcia, Gutierrez, Garcia Bascones, Relationship between obesity, diabetes and ICU admission in COVID-19 patients, Med Clin (Engl Ed)
Group, Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19, N Engl J Med
Group, Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial, Lancet
Guan, Clinical Characteristics of Coronavirus Disease 2019 in China, N Engl J Med
Hagg, Age, Frailty, and Comorbidity as Prognostic Factors for Short-Term Outcomes in Patients With Coronavirus Disease 2019 in Geriatric Care, J Am Med Dir Assoc
Health, Saudi MoH Protocol for Patients Suspected of/Confirmed with COVID-19
Hung, Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial, Lancet
Luzi, Radaelli, Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic, Acta Diabetol
Moh, None
Nishiura, Linton, Akhmetzhanov, Serial interval of novel coronavirus (COVID-19) infections, Int J Infect Dis
O. B. O. T, Network, The, Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study, Intensive Care Med
Obied, Alhamlan, Al-Qahtani, Al-Ahdal, Containment of COVID-19: the unprecedented response of Saudi Arabia, J Infect Dev Ctries
Onder, Rezza, Brusaferro, Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy, JAMA
Shi, Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study, Lancet Infect Dis
Snow, Creation and maintenance of a table for assessment of evolving evidence for COVID-19-related treatments, Am J Health Syst Pharm
Stat, COVID-19 CORONAVIRUS PANDEMIC STATISTICS
Takla, Jeevaratnam, Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety, Saudi Pharm J
Wang, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res
Who, Coronavirus
Wu, Mcgoogan, Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention, JAMA
Zhu, A Novel Coronavirus from Patients with Pneumonia in China, 2019, N Engl J Med
{ 'institution': [{'name': 'medRxiv'}],
'indexed': {'date-parts': [[2022, 3, 30]], 'date-time': '2022-03-30T03:03:21Z', 'timestamp': 1648609401975},
'posted': {'date-parts': [[2021, 7, 16]]},
'group-title': 'Epidemiology',
'reference-count': 31,
'publisher': 'Cold Spring Harbor Laboratory',
'content-domain': {'domain': [], 'crossmark-restriction': False},
'accepted': {'date-parts': [[2021, 7, 16]]},
'abstract': '<jats:title>Abstract</jats:title><jats:p>Severe acute respiratory syndrome coronavirus 2 '
'(SARS-CoV-2) is the causative agent of the catastrophic coronavirus disease 2019 (COVID-19) '
'global pandemic. This study aimed to provide epidemiologic and clinical characteristics of '
'patients with confirmed COVID-19 in Saudi Arabia and to determine whether characteristic '
'profiles differ between patients who are symptomatic vs. asymptomatic for the disease. The '
'first 492 consecutive patients diagnosed with SARS-CoV-2 infection at King Faisal Specialist '
'Hospital and Research Centre in Saudi Arabia between March and September 2020 were included '
'in this study. An electronic case report form developed using REDCap was used to collect data '
'for each patient, including demographic characteristics, virus exposure (travel history, and '
'human and animal contact), vaccination history, comorbidities, signs and symptoms, laboratory '
'and radiographic reports, cardiac workup, medications, treatment regimens, and patient '
'outcome. This patient cohort was 54% male, with 20.4% aged more than 60 years, 19.9% aged 31 '
'to 40 years, and 17% aged 41 to 50 years. Most patients (79.2%) were symptomatic. Variables '
'that significantly differed between symptomatic and asymptomatic patients were age, blood '
'oxygen saturation percentage, hemoglobin level, lymphocyte count, neutrophil to lymphocyte '
'(NTL) ratio, alanine aminotransferase (ALT) level, and aspartate aminotransferase (AST) '
'level. Asymptomatic patients were mostly younger, with lower body mass index and ALT and AST '
'levels but higher lymphocyte counts, NTL ratio, and CD4, CD8, natural killer cell, IgG, and '
'IgM levels. The median incubation period reported for this cohort was 16 day, with upper and '
'lower 95% quartiles of 27 and 10 days, respectively. Factors associated with increased risk '
'of mortality were age (older than 42 years) and comorbidities, including specifically '
'diabetes mellitus and hypertension. Patients who were not given an antiviral regimen were '
'associated with better prognosis than patients who received an antiviral regimen (HR, 0.07; '
'95% CI, 0.011-0.25). Similar to countries worldwide, Saudi Arabia has explored treatment '
'options to save the lives of patients during the COVID-19 pandemic. Our analyses will inform '
'clinicians as well as policy makers to adopt the best strategies for SARS-CoV-2 infection '
'management and treatment options.</jats:p>',
'DOI': '10.1101/2021.07.13.21260428',
'type': 'posted-content',
'created': {'date-parts': [[2021, 7, 16]], 'date-time': '2021-07-16T22:05:15Z', 'timestamp': 1626473115000},
'source': 'Crossref',
'is-referenced-by-count': 0,
'title': 'Epidemiology and Clinical Characteristics in Individuals with Confirmed SARS-CoV-2 Infection '
'During the Early COVID-19 Pandemic in Saudi Arabia',
'prefix': '10.1101',
'author': [ { 'ORCID': 'http://orcid.org/0000-0003-1765-4310',
'authenticated-orcid': False,
'given': 'Fatimah S.',
'family': 'Alhamlan',
'sequence': 'first',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-1275-8324',
'authenticated-orcid': False,
'given': 'Reem S.',
'family': 'Almaghrabi',
'sequence': 'additional',
'affiliation': []},
{'given': 'Edward B.', 'family': 'Devol', 'sequence': 'additional', 'affiliation': []},
{'given': 'Anwar B.', 'family': 'Alotaibi', 'sequence': 'additional', 'affiliation': []},
{'given': 'Saleh M.', 'family': 'Alageel', 'sequence': 'additional', 'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-0251-1894',
'authenticated-orcid': False,
'given': 'Dalia A.',
'family': 'Obeid',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-1565-1829',
'authenticated-orcid': False,
'given': 'Basem M.',
'family': 'Alraddadi',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-0740-7869',
'authenticated-orcid': False,
'given': 'Sahar I.',
'family': 'Althawadi',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-0641-9617',
'authenticated-orcid': False,
'given': 'Maysoon S.',
'family': 'Mutabagani',
'sequence': 'additional',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0003-4584-5739',
'authenticated-orcid': False,
'given': 'Ahmed A.',
'family': 'Al-Qahtani',
'sequence': 'additional',
'affiliation': []}],
'member': '246',
'reference': [ { 'key': '2021071903551074000_2021.07.13.21260428v1.1',
'doi-asserted-by': 'publisher',
'DOI': '10.1056/NEJMoa2001017'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.2',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(20)30211-7'},
{ 'issue': '7',
'key': '2021071903551074000_2021.07.13.21260428v1.3',
'doi-asserted-by': 'crossref',
'first-page': '699',
'DOI': '10.3855/jidc.13203',
'article-title': 'Containment of COVID-19: the unprecedented response of Saudi Arabia',
'volume': '14',
'year': '2020',
'journal-title': 'J Infect Dev Ctries'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.4',
'unstructured': 'MOH, “ https://covid19.moh.gov.sa/ ”2021.'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.5',
'unstructured': 'W. Stat, “COVID-19 CORONAVIRUS PANDEMIC STATISTICS,” 2021.'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.6',
'unstructured': 'S. M. o. Health, “Saudi MoH Protocol for Patients Suspected of/Confirmed '
'with COVID-19,” 2020.'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.7',
'doi-asserted-by': 'publisher',
'DOI': '10.5582/bst.2020.01047'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.8',
'doi-asserted-by': 'publisher',
'DOI': '10.1038/s41422-020-0282-0'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.9',
'doi-asserted-by': 'publisher',
'DOI': '10.1056/NEJMoa2001282'},
{ 'issue': '2',
'key': '2021071903551074000_2021.07.13.21260428v1.10',
'doi-asserted-by': 'crossref',
'first-page': '154',
'DOI': '10.1093/ajhp/zxaa334',
'article-title': 'Creation and maintenance of a table for assessment of evolving evidence '
'for COVID-19-related treatments',
'volume': '78',
'year': '2021',
'journal-title': 'Am J Health Syst Pharm'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.11',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(20)31042-4'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.12',
'doi-asserted-by': 'publisher',
'DOI': '10.1093/aje/kwt133'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.13',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.ijid.2020.02.060'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.14',
'doi-asserted-by': 'crossref',
'first-page': '17',
'DOI': '10.12688/wellcomeopenres.15718.1',
'article-title': 'The transmissibility of novel Coronavirus in the early stages of the '
'2019-20 outbreak in Wuhan: Exploring initial point-source exposure '
'sizes and durations using scenario analysis',
'volume': '5',
'year': '2020',
'journal-title': 'Wellcome Open Res'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.15',
'doi-asserted-by': 'publisher',
'DOI': '10.1056/NEJMoa2002032'},
{ 'issue': '18',
'key': '2021071903551074000_2021.07.13.21260428v1.16',
'first-page': '1775',
'article-title': 'Case-Fatality Rate and Characteristics of Patients Dying in Relation to '
'COVID-19 in Italy',
'volume': '323',
'year': '2020',
'journal-title': 'JAMA'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.17',
'doi-asserted-by': 'crossref',
'unstructured': 'G. M. Bwire , “Coronavirus: Why Men are More Vulnerable to Covid-19 Than '
'Women?,” SN Compr Clin Med, pp. 1–3, Jun 4 2020.',
'DOI': '10.1007/s42399-020-00341-w'},
{ 'issue': '11',
'key': '2021071903551074000_2021.07.13.21260428v1.18',
'doi-asserted-by': 'crossref',
'first-page': '1555',
'DOI': '10.1016/j.jamda.2020.08.014',
'article-title': 'Age, Frailty, and Comorbidity as Prognostic Factors for Short-Term '
'Outcomes in Patients With Coronavirus Disease 2019 in Geriatric Care',
'volume': '21',
'year': '2020',
'journal-title': 'J Am Med Dir Assoc'},
{ 'issue': '4',
'key': '2021071903551074000_2021.07.13.21260428v1.19',
'doi-asserted-by': 'crossref',
'first-page': '425',
'DOI': '10.1016/S1473-3099(20)30086-4',
'article-title': 'Radiological findings from 81 patients with COVID-19 pneumonia in '
'Wuhan, China: a descriptive study',
'volume': '20',
'year': '2020',
'journal-title': 'Lancet Infect Dis'},
{ 'issue': '7',
'key': '2021071903551074000_2021.07.13.21260428v1.20',
'first-page': '314',
'article-title': 'Relationship between obesity, diabetes and ICU admission in COVID-19 '
'patients',
'volume': '155',
'year': '2020',
'journal-title': 'Med Clin (Engl Ed)'},
{ 'issue': '1',
'key': '2021071903551074000_2021.07.13.21260428v1.21',
'doi-asserted-by': 'crossref',
'first-page': '60',
'DOI': '10.1007/s00134-020-06294-x',
'article-title': 'Clinical characteristics and day-90 outcomes of 4244 critically ill '
'adults with COVID-19: a prospective cohort study',
'volume': '47',
'author': 'C.-I. G. o. b. o. t. R. Network and C.-I. C. U. I. the',
'year': '2021',
'journal-title': 'Intensive Care Med'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.22',
'doi-asserted-by': 'publisher',
'DOI': '10.1186/s12879-021-05950-x'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.23',
'unstructured': 'WHO, “Coronavirus,” 2020.'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.24',
'doi-asserted-by': 'publisher',
'DOI': '10.1001/jama.2020.2648'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.25',
'doi-asserted-by': 'publisher',
'DOI': '10.1007/s00592-020-01522-8'},
{ 'issue': '12',
'key': '2021071903551074000_2021.07.13.21260428v1.26',
'doi-asserted-by': 'crossref',
'first-page': '1760',
'DOI': '10.1016/j.jsps.2020.11.003',
'article-title': 'Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and '
'narrative synthesis of efficacy and safety',
'volume': '28',
'year': '2020',
'journal-title': 'Saudi Pharm J'},
{ 'issue': '1',
'key': '2021071903551074000_2021.07.13.21260428v1.27',
'doi-asserted-by': 'crossref',
'first-page': '2349',
'DOI': '10.1038/s41467-021-22446-z',
'article-title': 'Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 '
'from an international collaborative meta-analysis of randomized trials',
'volume': '12',
'year': '2021',
'journal-title': 'Nat Commun'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.28',
'doi-asserted-by': 'crossref',
'unstructured': 'R. C. Group , “Lopinavir-ritonavir in patients admitted to hospital with '
'COVID-19 (RECOVERY): a randomised, controlled, open-label, platform '
'trial,” Lancet, Oct 5 2020.',
'DOI': '10.2139/ssrn.3675410'},
{ 'issue': '21',
'key': '2021071903551074000_2021.07.13.21260428v1.29',
'doi-asserted-by': 'crossref',
'first-page': '2030',
'DOI': '10.1056/NEJMoa2022926',
'article-title': 'Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19',
'volume': '383',
'year': '2020',
'journal-title': 'N Engl J Med'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.30',
'doi-asserted-by': 'publisher',
'DOI': '10.1056/NEJMoa2023184'},
{ 'key': '2021071903551074000_2021.07.13.21260428v1.31',
'first-page': '639970',
'article-title': 'Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 '
'Patients: Findings From the Multicenter Italian CORIST Study',
'volume': '8',
'year': '2021',
'journal-title': 'Front Med (Lausanne)'}],
'container-title': [],
'original-title': [],
'link': [ { 'URL': 'https://syndication.highwire.org/content/doi/10.1101/2021.07.13.21260428',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2021, 7, 19]],
'date-time': '2021-07-19T10:55:41Z',
'timestamp': 1626692141000},
'score': 1,
'resource': {'primary': {'URL': 'http://medrxiv.org/lookup/doi/10.1101/2021.07.13.21260428'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 7, 16]]},
'references-count': 31,
'URL': 'http://dx.doi.org/10.1101/2021.07.13.21260428',
'relation': {},
'published': {'date-parts': [[2021, 7, 16]]},
'subtype': 'preprint'}